NASHUA, N.H., March 12 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced that John DeLucia has joined iCAD as the Vice President of Quality Assurance and Regulatory Affairs, reporting to iCAD President and CEO Ken Ferry. Mr. DeLucia brings more than 25 years of medical device, in-vitro diagnostics and biomedical research experience to this key management position. Mr. DeLucia has significant experience working with the FDA and other global regulatory authorities, and will be responsible for navigating iCAD through several anticipated FDA milestones. His expertise includes managing and directing regulatory submissions, compliance, clinical studies, quality assurance and laboratory services for medical device and clinical diagnostic products.
"We are delighted to have John join iCAD's management team," said Ken Ferry. "We are confident that John's experience and successful track record with the FDA and other regulatory agencies will be of tremendous value to iCAD as we execute on our growth strategy and bring new products to market."
"I am especially pleased to be joining iCAD at this exciting time, as we have an opportunity to bring several compelling cancer screening technologies through the regulatory process and on to commercialization," said Mr. DeLucia. "I look forward to being an integral part of iCAD's success."
Prior to joining iCAD, Mr. DeLucia served as Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance at Z-Tech Medical Inc., a medical device company that developed a novel bioimpedance breast scanning detection system. Mr. DeLucia was responsible for directing and managing clinical trials, global regulatory submissions, facility quality operations and reporting, and regulatory compliance activities.
Before joining Z-Tech Medical Inc., Mr. DeLucia was Vice President of
|SOURCE iCAD, Inc.|
Copyright©2008 PR Newswire.
All rights reserved